The list of compensated and free medicines was completed with 41 molecules, based on an ordinance approved on Thursday, November 20, by the Government, announced the Minister of Health, Alexandru Rogobete. In the case of rare diseases, state-of-the-art treatments are introduced for amyloidosis, hereditary angioedema or achondroplasia.
PHOTO Shutterstock
“Today we took one of the most important steps in recent years for Romanian patients: expanding the list of compensated and free medicines by 41 medicines and, at the same time, expanding the list of conditions for which existing medicines can be prescribed”said Alexandru Rogobete.
According to the Minister of Health, “it is a fundamental change that directly affects people’s lives” and “one of the biggest expansion packs in years”
“A direct result of the work of the teams from the Ministry of Health, ANMDMR and CNAS. I am proud that, together, we managed to introduce new, innovative, generic and biosimilar therapies, which bring the treatment closer to people and make the system more accessible and fairer. In parallel, the expansion of eligible conditions for the existing drugs makes the treatments more accessible to more patients. Through this extension, patients with oncological diseasesneurological, cardiovascular, rheumatological, pulmonological, dermatological, gastroenterological, hematological, ophthalmological, allergological and infectious diseases receive modern therapeutic options, scientifically validated and aligned with European standards”the official explained.
Alexandru Rogobete also specified that, “for rare diseases – where too often families have been alone – we introduce state-of-the-art treatments for amyloidosis, hereditary angioedema or achondroplasia”.
Areas where new treatments are introduced or expanded
oncologists
Advanced breast cancer
Metastatic colorectal cancer (CRC).
Castration-resistant non-metastatic prostate cancer
Metastatic or locally advanced breast cancer
Advanced non-small cell lung cancer (NSCLC).
Advanced medullary thyroid cancer
Advanced prostate cancer
Metastatic prostate cancer
Leukemia
Relapsed and refractory multiple myeloma
Uveal melanoma
Biliary tract cancer
NEUROLOGY
Migraine treatment
Epilepsy
Myasthenia gravis
RHEUMATOLOGY
Psoriatic arthritis
Axial spondyloarthritis
DERMATOLOGY
Atopic dermatitis
Pneumology
Chronic Obstructive Pulmonary Disease (COPD)
Severe bronchial asthma
ENDOCRINOLOGY
Primary hypercholesterolemia (heterozygous familial / non-familial)
Mixed dyslipidemia
OPHTHALMOLOGY
Neovascular macular degeneration
Diabetic macular edema
HEMATOLOGY
Severe thrombocytopenia
PEDIATRICS
Treatment of achondroplasia
Multidisciplinary areas (Cardiology + Neurology)
Transthyretin amyloidosis
Essential hypertension
GASTROENTEROLOGY
Ulcerative colitis
Allergists
Hereditary angioedema
INFECTIOUS DISEASES
New drug combinations for the treatment of HIV infection
